Evaluation of Subconjunctival Bevacizumab as an Adjunct to Trabeculectomy

Honjo, 2007, Potential role of Rho-associated protein kinase inhibitor Y-27632 in glaucoma filtration surgery, Invest Ophthalmol Vis Sci, 48, 5549, 10.1167/iovs.07-0878 Addicks, 1983, Histologic characteristics of filtering blebs in glaucomatous eyes, Arch Ophthalmol, 101, 795, 10.1001/archopht.1983.01040010795021 Hitchings, 1983, Clinico pathological correlation in eyes with failed fistulizing surgery, Trans Ophthalmol Soc U K, 103, 84 Khaw, 1994, Activation and suppression of fibroblast function, Eye, 8, 188, 10.1038/eye.1994.44 Fontana, 2006, Trabeculectomy with mitomycin C: outcomes and risk factors for failure in phakic open-angle glaucoma, Ophthalmology, 113, 930, 10.1016/j.ophtha.2006.01.062 Singh, 2001, The efficacy and safety of intraoperative and/or postoperative 5-fluorouracil in trabeculectomy and phacotrabeculectomy, Clin Experiment Ophthalmol, 29, 296, 10.1046/j.1442-9071.2001.00437.x Lama, 2003, Antifibrotics and wound healing in glaucoma surgery, Surv Ophthalmol, 48, 314, 10.1016/S0039-6257(03)00038-9 Stamper, 1992, Hypotonous maculopathy after trabeculectomy with subconjunctival 5-fluorouracil, Am J Ophthalmol, 114, 544, 10.1016/S0002-9394(14)74481-2 2007, A phase III study of subconjunctival human anti-transforming growth factor beta (2) monoclonal antibody (CAT-152) to prevent scarring after first-time trabeculectomy, Ophthalmology, 114, 1822, 10.1016/j.ophtha.2007.03.050 Mead, 2003, Evaluation of anti-TGF-beta2 antibody as a new postoperative anti-scarring agent in glaucoma surgery, Invest Ophthalmol Vis Sci, 44, 3394, 10.1167/iovs.02-0978 Eibl, 2004, Alkylphosphocholines: a new therapeutic option in glaucoma filtration surgery, Invest Ophthalmol Vis Sci, 45, 2619, 10.1167/iovs.03-1351 Meyer-ter-Vehn, 2006, p38 inhibitors prevent TGF-beta-induced myofibroblast transdifferentiation in human tenon fibroblasts, Invest Ophthalmol Vis Sci, 47, 1500, 10.1167/iovs.05-0361 Wells, 2004, A pilot study of a system for grading of drainage blebs after glaucoma surgery, J Glaucoma, 13, 454, 10.1097/00061198-200412000-00005 Foster, 2004, Defining “occludable” angles in population surveys: drainage angle width, peripheral anterior synechiae, and glaucomatous optic neuropathy in east Asian people, Br J Ophthalmol, 88, 486, 10.1136/bjo.2003.020016 Kahook, 2006, Intravitreal bevacizumab in a patient with neovascular glaucoma, Ophthalmic Surg Lasers Imaging, 37, 144, 10.3928/1542-8877-20060301-11 Gheith, 2007, Role of intravitreal bevacizumab in neovascular glaucoma, J Ocul Pharmacol Ther, 23, 487, 10.1089/jop.2007.0036 Yazdani, 2007, Intravitreal bevacizumab (Avastin) injection for neovascular glaucoma, J Glaucoma, 16, 437, 10.1097/IJG.0b013e3180457c47 Jonas, 2007, Intravitreal bevacizumab for filtering surgery, Ophthalmic Res, 39, 121, 10.1159/000099248 Khaw, 2001, Modulation of wound healing after glaucoma surgery, Curr Opin Ophthalmol, 12, 143, 10.1097/00055735-200104000-00011 Amano, 1998, Requirement for vascular endothelial growth factor in wound and inflammation-related corneal neovascularization, Invest Ophthalmol Vis Sci, 39, 18 Jin, 2003, Decreased pigment epithelium-derived factor and increased vascular endothelial growth factor levels in pterygia, Cornea, 22, 473, 10.1097/00003226-200307000-00015 Jacobi, 2004, Discordant effects of a soluble VEGF receptor on wound healing and angiogenesis, Gene Ther, 11, 302, 10.1038/sj.gt.3302162 Kahook, 2006, Needle bleb revision of encapsulated filtering bleb with bevacizumab, Ophthalmic Surg Lasers Imaging, 37, 148, 10.3928/1542-8877-20060301-12 Jampel, 1988, Cellular proliferation after experimental glaucoma filtration surgery, Arch Ophthalmol, 106, 89, 10.1001/archopht.1988.01060130095036 Watanabe, 1997, Effects of mitomycin C on expression of proliferating cell nuclear antigen after filtering surgery in rabbits, Graefes Arch Clin Exp Ophthalmol, 35, 234, 10.1007/BF00941765 Wong, 1994, Modulation of human fibroblast activity by selected angiogenesis inhibitors, Exp Eye Res, 58, 439, 10.1006/exer.1994.1037 Kano, 2005, VEGF-A and FGF-2 synergistically promote neoangiogenesis through enhancement of endogenous PDGF-B-PDGFRbeta signaling, J Cell Sci, 118, 3759, 10.1242/jcs.02483 Asahara, 1995, Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo, Circulation, 92, II365, 10.1161/01.CIR.92.9.365 Seghezzi, 1998, Fibroblast growth factor-2 (FGF-2) induces vascular endothelial growth factor (VEGF) expression in the endothelial cells of forming capillaries: an autocrine mechanism contributing to angiogenesis, J Cell Biol, 141, 1659, 10.1083/jcb.141.7.1659 Corral, 1999, Vascular endothelial growth factor is more important than basic fibroblastic growth factor during ischemic wound healing, Arch Surg, 134, 200, 10.1001/archsurg.134.2.200 Beer, 2006, Vitreous levels of unbound bevacizumab and unbound vascular endothelial growth factor in two patients, Retina, 26, 871, 10.1097/01.iae.0000233327.68433.02 Bakri, 2007, Pharmacokinetics of intravitreal bevacizumab (Avastin), Ophthalmology, 114, 855, 10.1016/j.ophtha.2007.01.017 Grisanti, 2006, Intracameral bevacizumab for iris rubeosis, Am J Ophthalmol, 142, 158, 10.1016/j.ajo.2006.02.045 Chalam, 2008, Intracameral Avastin dramatically resolves iris neovascularization and reverses neovascular glaucoma, Eur J Ophthalmol, 18, 255, 10.1177/112067210801800214 Cheung, 1997, Intermediate-term outcome of variable dose mitomycin C filtering surgery, Ophthalmology, 104, 143, 10.1016/S0161-6420(97)30347-9 Perkins, 1998, Trabeculectomy with mitomycin C: intermediate-term results, J Glaucoma, 7, 230, 10.1097/00061198-199808000-00003 Cillino, 2008, Deep sclerectomy versus trabeculectomy with low-dosage mitomycin C: four-year follow-up, Ophthalmologica, 222, 81, 10.1159/000112623